VanEck Pharmaceutical ETF (PPH)
NASDAQ: PPH
· Real-Time Price · USD
88.05
0.72 (0.82%)
At close: Aug 19, 2025, 11:47 AM
0.82% (1D)
| Bid | 88.06 |
| Market Cap | 1.02B |
| AUM | 527.38M |
| NAV | 87.34 |
| EPS (ttm) | 3.83 |
| PE Ratio (ttm) | 23.00 |
| Shares Out | 11.55M |
| Inception Date | Dec 20, 2011 |
| Ask | 88.08 |
| Volume | 497.74K |
| Open | 87.88 |
| Previous Close | 87.33 |
| Day's Range | 87.81 - 88.42 |
| 52-Week Range | 77.67 - 99.51 |
| Holdings | 25 |
| Expense Ratio | 0.36% |
About PPH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Asset Class Equity
Ticker Symbol PPH
Inception Date Dec 20, 2011
Provider Vaneck
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 72.18% of assets
| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly And Compan... | LLY | 16.60% |
| Johnson & Johnson | JNJ | 11.71% |
| Novartis Ag | NVS | 7.84% |
| Merck & Co., Inc. | MRK | 6.24% |
| Novo Nordisk A/s | NVO | 5.70% |
| Abbvie Inc. | ABBV | 5.05% |
| Astrazeneca PLC | AZN | 5.03% |
| Pfizer Inc. | PFE | 4.85% |
| Sanofi | SNY | 4.66% |
| Bristol-myers Squibb... | BMY | 4.50% |
Dividends Dividend Yield 2.21%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Jul 1, 2025 | $0.6069 | Jul 7, 2025 |
| Apr 1, 2025 | $0.5245 | Apr 4, 2025 |
| Dec 27, 2024 | $0.4110 | Dec 30, 2024 |
| Oct 1, 2024 | $0.4090 | Oct 4, 2024 |
| Jul 1, 2024 | $0.3558 | Jul 5, 2024 |
